Difference between revisions of "Buonamici S, et al. Sci. Transl. Med. (2010) cited as Ref 230 in DOI: 10.1038/s41392-020-0110-5 (Q9493)"
Jump to navigation
Jump to search
(Created claim: DOI Identifier (P138): 10.1126/scitranslmed.3001599, #quickstatements; #temporary_batch_1590000649558) |
(Created claim: Page(s) (P105): 51ra70-, #quickstatements; #temporary_batch_1590074839150) |
||||||||||||||
| (5 intermediate revisions by the same user not shown) | |||||||||||||||
| Property / PubMed ID | |||||||||||||||
| + | |||||||||||||||
| Property / PubMed ID: 20881279 / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / Publication Date | |||||||||||||||
| + | 2010
| ||||||||||||||
| Property / Publication Date: 2010 / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / Published In Name String | |||||||||||||||
| + | Sci. Transl. Med. | ||||||||||||||
| Property / Published In Name String: Sci. Transl. Med. / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / Volume | |||||||||||||||
| + | 2 | ||||||||||||||
| Property / Volume: 2 / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / title | |||||||||||||||
| + | Interfering with resistance to smoothened antagonists by inhibition of the PI3K pathway in medulloblastoma (English) | ||||||||||||||
| Property / title: Interfering with resistance to smoothened antagonists by inhibition of the PI3K pathway in medulloblastoma (English) / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / Page(s) | |||||||||||||||
| + | 51ra70- | ||||||||||||||
| Property / Page(s): 51ra70- / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
Latest revision as of 15:34, 21 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Buonamici S, et al. Sci. Transl. Med. (2010) cited as Ref 230 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Buonamici S
0 references
2010
0 references
Sci. Transl. Med.
0 references
2
0 references
Interfering with resistance to smoothened antagonists by inhibition of the PI3K pathway in medulloblastoma (English)
0 references
51ra70-
0 references
